Bioxyne Ltd : Appointment of Guy Robertson as chief operating officer and chief financial officer with effect from today .
Bioxyne Ltd : Signed an agreement with datapharm Australia to undertake a clinical trial . Says agreement to undertake a clinical trial to support its Australian launch and marketing of progastrim® and protract .
* Requests trading halt pending announcement in relation to
an acquisition and capital raising
Source text for Eikon:
Further company coverage: